Found 56 matching trials
A Study in Schizophrenia Patients PHASE2 An inpatient/outpatient study to see if LY2140023 is better than placebo in...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome PHASE2 OBJECTIVES: I. Conduct a randomized, double blind, placebo controlled, para...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant PHASE1 This is an Open-Label Study in Stable Schizophrenia Patients to Evaluate th...
Show More Location
Collaborative Neuroscience Research
Learn More & Join Trial
Early Phase II Trials for Cocaine Medication Development - 1 PHASE2 The purpose of this study is to develop models for early Phase II testing o...
Show More Location
NYS Psychiatric Institute
Learn More & Join Trial
A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone PHASE1 This randomized, double-blinded, placebo-controlled study will investigate ...
Show More Location
Multiple Locations
Learn More & Join Trial
The New Strategy for Pharmacological Treatment in People With Schizophrenia PHASE4 Switching from Risperidone to Aripiprazole in early stage of pharmacotherap...
Show More Learn More & Join Trial
Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy PHASE2 Evaluate the safety and tolerability of multiple subcutaneous injections of...
Show More Location
Woodland International Research Group, Inc.
Learn More & Join Trial
An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005) PHASE2 This will be a randomized, placebo-controlled, parallel-group, multi-site, ...
Show More Location
Woodland International Research Group, LLC ( Site 0001)
Learn More & Join Trial
A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia PHASE2 The objective of this study is to evaluate the long-term safety, tolerabili...
Show More Location
Multiple Locations
Learn More & Join Trial
β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS N/A The purpose of this study is to determine whether atypical antipsychotic dr...
Show More Learn More & Join Trial